Chemoinformatics Market

Chemoinformatics Market

Global Chemoinformatics Market reached US$ YY million in 2022 and is expected to reach US$ YY million by 2030, growing with a CAGR of YY % during the forecast period 2024-2031.

Cheminformatics is a relatively new field of information technology that focuses on the collection, storage, analysis, and manipulation of chemical data. The chemical data of interest typically includes information on small molecule formulas, structures, properties, spectra, and activities (biological or industrial). Cheminformatics originally emerged as a vehicle to help the drug discovery and development process, however cheminformatics present plays an increasingly important role in many areas of biology, chemistry, and biochemistry.

Chemoinformatics plays a crucial role in drug discovery by predicting the biological activity of molecules, identifying potential drug candidates, and optimizing molecular structures for enhanced therapeutic effects. Integrating chemoinformatics with bioinformatics to understand the interactions between chemical compounds and biological systems, facilitating interdisciplinary research.

Market Dynamics: Drivers and Restraints

Rising in the AI-enabled drug discovery methods

Companies hoping to leverage AI need a full view of all their data, not just bits and pieces. This demands a research infrastructure that lets computational and experimental teams collaborate, uniting workflows and sharing data across domains and locations. Careful process and methodology standardization are also needed to ensure that results obtained with the help of AI are repeatable.

For instance, in January 2024, Deloitte announced Atlas AI, the latest addition to its Quartz AI suite of cross-industry solutions built on the NVIDIA AI and NVIDIA Omniverse platforms. By using Generative AI models made accessible with BioNeMo, knowledge representation and reasoning, and custom protein Large Language Models (LLMs) and chemoinformatics LLMs, Atlas AI advances digital biology and transforms drug discovery with the latest AI technologies.

Moreover, in May 2023, Google Cloud announced two new AI-powered life sciences solutions to accelerate drug discovery and precision medicine for biotech companies, pharmaceutical firms, and public sector organizations. Available worldwide, the Target and Lead Identification Suite helps researchers better identify the function of amino acids and predict the structure of proteins; and the Multiomics Suite accelerates the discovery and interpretation of genomic data, helping companies design precision treatments. Thus above factors helps to boost the market growth.

Market Dynamics: Restraint

The lack of skilled professionals

The effective utilization of chemoinformatics tools requires skilled professionals who can understand and interpret the results. The shortage of experts in both computational chemistry and informatics may limit the widespread adoption of these tools. For instance, the fields of biology, informatics, and chemistry come together in chemoinformatics. Experts in this field must possess a thorough understanding of data analysis, computational chemistry, and chemoinformatics-specific software tools. The specialised nature of these skills makes it difficult to locate experts in the field.

Additionally, it can be difficult to provide chemoinformatics with the necessary training, as the field calls for a certain set of abilities that aren't always included in conventional curricula. If these abilities are not quickly incorporated into academic curricula, there may be a scarcity of professionals with the necessary education and experience. Thus above factors restrain the market growth.

For more details of the report, Request for sample

Segment Analysis

The global chemoinformatics market is segmented based on type, application, end-user and region.

The software segment from the type segment accounted for approximately 39.7% of share

Chemoinformatics software is essential in drug discovery for virtual screening, lead identification, and optimization of drug candidates. Chemoinformatics software enables molecular modeling, helping researchers understand the 3D structure of molecules and predict their behavior in different environments. Molecular dynamics simulations and docking studies are conducted using chemoinformatics tools to study molecular interactions, aiding in drug design and optimization.

The software tools like Marvin Suite by ChemAxon offers tools for chemical drawing, structure-based prediction, and database management, and an open-source toolkit for cheminformatics, RDKit provides a wide range of functionality, including molecular structure handling, descriptor calculation, and chemoinformatics analysis.

Additionally, Chemoinformatics software incorporates predictive modeling and machine learning algorithms to make predictions about chemical properties, bioactivity, and toxicity. These models help prioritize compounds for experimental testing, reducing the time and resources required for drug development. Thus due to advance features and solutions of the software help sto boost the segment growth.

Geographical Analysis

North America accounted for approximately 42.4% of the market share in 2022

North America will be dominate the market region due to the high R&D intensity and the incorporation of highly innovative technologies, the increasing prevalence of chronic disorders, and the presence of some of the major players in the drug manufacturing industry. For instance, according to CDC, estimated that, six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care costs.

Additionally, new approvals and launches of various platforms, and the presence of many key players in the region. For instance, in July 2022, Dotmatics, released of its Small Molecule Drug Discovery Solution, an integrated scientific R&D platform with pre-configured workflows and expanded data management capabilities. The solution helps companies innovate more easily by leveraging best practices derived from the company's 15+ years of experience supporting small molecule drug discovery. Thus, above factors help to boost the region growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has led to a spike in research output surrounding all aspects of the disease, ranging in scale from the molecular to the population level. There have been many preprints (and subsequent journal publications) in the field of cheminformatics that attempt to address the discovery of therapeutics against the disease. The pandemic underscored the critical importance of drug discovery and development.

Cheminformatics plays a crucial role in this process by utilizing computational methods to analyze and interpret chemical data. The demand for new drugs and therapeutic solutions might have increased, potentially boosting the cheminformatics market. The pandemic has accelerated the adoption of remote work. This trend may have influenced the cheminformatics market, as remote access to computational tools and databases becomes more essential. Companies offering cloud-based cheminformatics solutions may have experienced increased demand.

Market Segmentation

By Type
• Software
• Services

By Application
• Drug Discovery
• Chemical Analysis
• Molecular Modeling
• Others

By End-User
• Pharmaceutical and Biotechnology Companies
• Food & Beverages Companies
• Chemical Industries
• Academic and Research Institutions
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Dassault Systèmes, Chemical Computing Group ULC, Scilligence, Schrödinger, LLC, ChemAxon, Inc, Harmonic Discovery Inc, Oxford Drug Design, Kaipharm, Aganitha AI Inc, Jubilant Biosys and among others.

Key Developments
• On January 13, 2022, Discngine, partnered with ChemAxon, a leading cheminformatics and bioinformatics company. By joining forces, partners expect to streamline pharma and biotech research involving complex biomolecular structural data. Discngine’s 3decision platform stores, categorizes and analyzes protein-ligand structural data in a centralized knowledge base. Its fundamental value includes the automatic transformation of protein structural data generated over time into valuable knowledge, easily accessible by scientists for convenient structure-based discoveries.
• In November 2020, Drug discovery software developer, Optibrium, had partnered with Merck & Co for the integration of Optibrium’s software into MSD’s drug discovery infrastructure. The agreement covers the integration of Optibrium’s StarDrop software as a central component of MSD’s cheminformatics infrastructure.

Why Purchase the Report?
• To visualize the global chemoinformatics market segmentation based on type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of chemoinformatics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global chemoinformatics market report would provide approximately 69 tables, 58 figures and 187 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies